Calcium Antagonists in Coronary Artery Disease and Hypertension
Author:
- 1 September 1995
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 92 (5) , 1079-1082
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Calcium antagonists in the treatment of ischemic heart diseaseCoronary Artery Disease, 1994
- The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)Archives of internal medicine (1960), 1993
- Update of effects of calcium antagonists in myocardial infarction or angina in light of the second danish verapamil infarction trial (DAVIT-II) and other recent studiesThe American Journal of Cardiology, 1991
- Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial II — DAVIT II)The American Journal of Cardiology, 1990
- Retardation of angiographic progression of coronary artery disease by nifedipineThe Lancet, 1990
- Blood pressure, stroke, and coronary heart diseaseThe Lancet, 1990
- Blood pressure, stroke, and coronary heart disease *1Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution biasThe Lancet, 1990
- The Effect of Diltiazem on Mortality and Reinfarction after Myocardial InfarctionNew England Journal of Medicine, 1988
- Early treatment of unstable angina in the coronary care unit: a randomised, double blind, placebo controlled comparison of recurrent ischaemia in patients treated with nifedipine or metoprolol or both. Report of The Holland Interuniversity Nifedipine/Metoprolol Trial (HINT) Research Group.Heart, 1986
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985